Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/761
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYakubova, Markhamat-
dc.date.accessioned2024-12-26T13:01:49Z-
dc.date.available2024-12-26T13:01:49Z-
dc.date.issued2024-
dc.identifier.issn2181-4988-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/761-
dc.description.abstractCognitive impairment in patients with type 2 diabetes mellitus is one of the actual problems not only of neurology, but also of geriatric medicine. Cognitive impairment is one of the main factors influencing the quality and life expectancy of patients, achieving full effectiveness of the process of treating the underlying disease - diabetes, as well as the formation of an adequate worldview of the patient to his illness.The study involved 126 patients undergoing inpatient treatment. The MMSE test and blood glycemic indicators were studied. In patients with type 2 diabetes mellitus and stage 3 chronic cerebral ischemia, increasingly severe cognitive impairment is observed. Cognitive impairment is directly proportional to blood glycemic indicators. These indicators show that the role of persistent hyperglycemia in the development of cognitive impairment is significant and has a negative impact on cognitive performance.en_US
dc.relation.ispartofseries№ 3;-
dc.subjectСognitive dysfunction, diabetes mellitus, cognitive disorders, chronic cerebral ischemia, glycohemoglobin, encephalopathy.en_US
dc.titleThe relationship between cognitive impairment and glycemic parameters in patients with type 2 diabetes mellitusen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
04_THE_RELATIONSHIP_BETWEEN_COGNITIVE_IMPAIRMENT_AND_GLYCEMIC_PARAMETERS.pdf3.7 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.